Purchases and Sales Made in Q3 2022 in Transcode Therapeutics, Inc. (RNAZ)
This table provides information about the institutional ownership of Transcode Therapeutics, Inc. (RNAZ) during Q3 2022. The information is specifically focused on institutions that hold shares of Transcode Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
86New |
$86.9 - $81.9K
|
86
$330
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
4+ 8.89% |
$4.04 - $3.81K
|
49
$188
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Redmond Asset Management, LLC
Henrico, VA |
SELL
|
- |
-160- 0.18% |
$162 - $152K
|
90.9K
$349K
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-430- 2.73% |
$434 - $409K
|
15.3K
$58.9K
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-512- 8.51% |
$517 - $487K
|
5.51K
$21.1K
|